发明名称 PHARMACEUTICAL COMPOSITION FOR TREATING HEMORRHAGE CAUSED BY BLOOD CLOTTING DISORDER AND USE THEREOF
摘要 <p>The present invention belongs to the emergency treatment field of critically ill patients and involves a pharmaceutical composition used to treat coagulation disorder hemorrhage and its purpose and methods to treat the patients bleeding due to coagulation disorder. Containing L-ornithine 0.5ˆ¼8g, aspartic acid 1ˆ¼5g, arginine 3~10g and vitamin B6 3-10g per unit, the pharmaceutical composition is effective in treating the hemorrhagic patients caused by coagulation dysfunction, especially in treating critically ill patients.</p>
申请公布号 EP2601951(A1) 申请公布日期 2013.06.12
申请号 EP20100855546 申请日期 2010.12.10
申请人 YUE, MAOXING;WAN, HONGGUI;HUANG, TONGGE 发明人 YUE, MAOXING;WAN, HONGGUI;HUANG, TONGGE
分类号 A61K31/4415;A61K31/197;A61K31/198;A61K31/375;A61K31/401;A61K31/405;A61K31/4172;A61K31/4188;A61K31/455;A61K31/51;A61K31/519;A61K31/525;A61K31/714;A61P7/04 主分类号 A61K31/4415
代理机构 代理人
主权项
地址